Zobrazeno 1 - 10
of 198
pro vyhledávání: '"JM Pagel"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S162- (2023)
Objectives: Venetoclax-based therapy is a standard option for pts with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) previously treated with a covalent BTK inhibitor (cBTKi). Pirtobrutinib is a highly selective, non-covalent (reversibl
Externí odkaz:
https://doaj.org/article/7d318f13915c476ba6fcf0221626f667
Autor:
Gyurkocza B; David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY., Nath R; Banner MD Anderson Cancer Center, Gilbert, AZ., Seropian S; Yale University School of Medicine-Yale Cancer Center, New Haven, CT., Choe H; The Ohio State University, Columbus, OH., Litzow MR; Mayo Clinic, Rochester, MN., Abboud C; Washington University School of Medicine, St Louis, MO., Koshy N; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX., Stiff P; Loyola University Medical Center, Maywood, IL., Tomlinson B; University Hospitals Cleveland Medical Center, Cleveland, OH., Abhyankar S; University of Kansas Cancer Center, Kansas City, KS., Foran J; Mayo Clinic, Jacksonville, FL., Hari P; Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, WI., Chen G; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; MD Anderson Cancer Center, Houston, TX., Al-Kadhimi Z; University of Nebraska Medical Center, Omaha, NE., Kebriaei P; MD Anderson Cancer Center, Houston, TX., Sabloff M; University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Orozco JJ; Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA., Jamieson K; University of North Carolina (UNC), Chapel Hill, NC., Silverman M; University of Iowa, Iowa City, IA., Van Besien K; Weill Cornell Medical College, New York, NY., Schuster M; Stony Brook University Cancer Center, Stony Brook, NY., Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada., Larkin K; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH., Pandit-Taskar N; Department of Radiology, Memorial Sloan Kettering, New York, NY., Rowley SD; Hackensack University Medical Center, Hackensack, NJ., Munshi P; MedStar Georgetown University Hospital, Washington, DC., Cook R; Oregon Health & Science University, Portland, OR., Levy MY; Baylor Scott & White Health, Dallas, TX., Lazarus HM; Case Western Reserve University, Cleveland, OH., Sandmaier BM; Fred Hutchinson Cancer Center and University of Washington School of Medicine, Seattle, WA., Pagel JM; Loxo Oncology at Lilly, Stamford, CT., Reddy V; D2V Clinical, Raleigh, Durham, NC., MacDougall J; Statistical Consultant to Actinium Pharmaceuticals, New York, NY., McNamara K; Actinium Pharmaceuticals, New York, NY., Spross J; Actinium Pharmaceuticals, New York, NY., Haeuber E; Actinium Pharmaceuticals, New York, NY., Vusirikala M; Actinium Pharmaceuticals, New York, NY., Nahar A; Actinium Pharmaceuticals, New York, NY., Desai A; Actinium Pharmaceuticals, New York, NY., Giralt S; David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 19, pp. JCO2302018. Date of Electronic Publication: 2024 Sep 19.
Autor:
Pagel JM; Department of Otolaryngology-Head and Neck Surgery, University of Virginia, Charlottesville, Virginia, U.S.A., Taffe E; Human Services Department, University of Virginia, Charlottesville, Virginia, U.S.A., Jonas RH; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, U.S.A., Daniero JJ; Department of Otolaryngology-Head and Neck Surgery, University of Virginia, Charlottesville, Virginia, U.S.A., Mason K; Human Services Department, University of Virginia, Charlottesville, Virginia, U.S.A., McGarey PO Jr; Department of Otolaryngology-Head and Neck Surgery, University of Virginia, Charlottesville, Virginia, U.S.A.
Publikováno v:
The Laryngoscope [Laryngoscope] 2024 Nov; Vol. 134 (11), pp. 4642-4648. Date of Electronic Publication: 2024 Jul 15.
Autor:
Zhang MY; Department of Medicine, University of Washington, Seattle, WA, USA., Othus M; SWOG Statistical and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., McMillen K; Fred Hutchinson Medical Nutrition Therapy Services, Fred Hutchinson Cancer Center, Seattle, WA, USA., Erba HP; Duke Cancer Institute, Durham, NC, USA., Garcia-Manero G; MD Anderson Cancer Center, Houston, TX, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Sorror ML; Department of Medicine, University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Percival MM; Department of Medicine, University of Washington, Seattle, WA, USA. mperciva@uw.edu.; Fred Hutchinson Cancer Center, Seattle, WA, USA. mperciva@uw.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1488-1493. Date of Electronic Publication: 2024 Jun 03.
Autor:
Al-Sawaf O; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Germany; Cancer Institute, University College London, United Kingdom; Francis Crick Institute, London. othman.al-sawaf@uk-koeln.de., Jen MH; Eli Lilly and Company, Bracknell., Hess LM; Eli Lilly and Company, Indianapolis, IN., Zhang J; TechDataServices, LLC, King of Prussia, PA., Goebel B; Eli Lilly and Company, Bad Homburg., Pagel JM; LOXO@Lilly, Indianapolis, IN., Abhyankar S; Eli Lilly and Company, Indianapolis, IN., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Eyre TA; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford.
Publikováno v:
Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1866-1873. Date of Electronic Publication: 2024 Jun 01.
Autor:
Orozco JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Vo PT; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington., Haaf RL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Lundberg SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hamlin DK; Radiation Oncology, University of Washington School of Medicine, Seattle, Washington., Wilbur DS; Radiation Oncology, University of Washington School of Medicine, Seattle, Washington., Matesan MC; Nuclear Medicine, University of Washington School of Medicine, Seattle, Washington., Fisher DR; Versant Medical Physics and Radiation Safety, Richland, Washington., Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Pagel JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 274-282.
Autor:
Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Podoltsev NA; Yale School of Medicine, New Haven, CT, USA. nikolai.podoltsev@yale.edu., Othus M; SWOG Statistics and Data Management Center, Seattle, WA, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Rizzieri DA; Duke University Medical Center, Durham, NC, USA., Marcucci G; Ohio State University (Alliance), Columbus, OH, USA.; City of Hope, Duarte, CA, USA., Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Litzow MR; Mayo Clinic, Rochester, MN, USA., Savoie ML; Tom Baker Cancer Centre, Calgary, AB, Canada., Medeiros BC; Stanford University, Stanford, CA, USA., Sekeres MA; Cleveland Clinic, Cleveland, OH, USA.; University of Miami, Maiami, FL, USA., Lin TL; University of Kansas Medical Center, Kansas City, KS, USA., Uy GL; Washington University School of Medicine, St. Louis, USA., Powell BL; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Kolitz JE; North Shore University Hospital, Manhasset, NY, USA., Larson RA; University of Chicago, Chicago, IL, USA., Stone RM; Dana Farber Cancer Institute, Boston, MA, USA., Claxton D; Pennsylvania State Milton S Hershey Medical Center, Hummelstown, USA., Essell J; Jewish Hospital, Cincinnati, OH, USA., Luger SM; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Mohan SR; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Moseley A; SWOG Statistics and Data Management Center, Seattle, WA, USA., Appelbaum FR; Fred Hutchinson Cancer Center, Seattle, WA, USA., Erba HP; Duke University Cancer Center, Durham, NC, USA.
Publikováno v:
Leukemia [Leukemia] 2024 Jan; Vol. 38 (1), pp. 58-66. Date of Electronic Publication: 2023 Nov 07.
Autor:
Westin JR; The University of Texas MD Anderson Cancer Center, Houston, Texas., Locke FL; Moffitt Cancer Center, Tampa, Florida., Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the University of Melbourne, Melbourne, Victoria, Australia., Ghobadi A; Washington University School of Medicine, St. Louis, Missouri., Elsawy M; Division of Hematology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada., van Meerten T; University Medical Center Groningen, Groningen, The Netherlands, on behalf of HOVON/LLPC., Miklos DB; Stanford University School of Medicine, Stanford, California., Ulrickson ML; Banner MD Anderson Cancer Center, Gilbert, Arizona., Perales MA; Memorial Sloan-Kettering Cancer Center, New York, New York., Farooq U; University of Iowa, Iowa City, Iowa., Wannesson L; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland., Leslie L; John Theurer Cancer Center, Hackensack, New Jersey., Kersten MJ; Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands, on behalf of HOVON/LLPC., Jacobson CA; Dana-Farber Cancer Institute, Boston, Massachusetts., Pagel JM; Swedish Cancer Institute, Seattle, Washington., Wulf G; University Medicine Göttingen, Göttingen, Germany., Johnston P; Mayo Clinic, Rochester, Minnesota., Rapoport AP; University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland., Du L; Kite, a Gilead Company, Santa Monica, California., Vardhanabhuti S; Kite, a Gilead Company, Santa Monica, California., Filosto S; Kite, a Gilead Company, Santa Monica, California., Shah J; Kite, a Gilead Company, Santa Monica, California., Snider JT; Kite, a Gilead Company, Santa Monica, California., Cheng P; Kite, a Gilead Company, Santa Monica, California., To C; Kite, a Gilead Company, Santa Monica, California., Oluwole OO; Vanderbilt University Cancer Center, Nashville, Tennessee., Sureda A; Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 May 15; Vol. 29 (10), pp. 1894-1905.
Autor:
Eyre TA; Oxford Cancer and Hematology Centre, Oxford University NHS Foundation Trust, Oxford, UK., Hess LM; Eli Lilly and Company, Indianapolis, IN, USA., Sugihara T; Syneos Health, Inc, Morrisville, NC, USA., He D; Syneos Health, Inc, Morrisville, NC, USA., Khanal M; Eli Lilly and Company, Indianapolis, IN, USA., Pagel JM; Loxo@Lilly, Indianapolis, IN, USA., Walgren RA; Loxo@Lilly, Indianapolis, IN, USA., B Abada P; Loxo@Lilly, Indianapolis, IN, USA., Konig H; Loxo@Lilly, Indianapolis, IN, USA., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mato A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 May; Vol. 64 (5), pp. 1005-1016. Date of Electronic Publication: 2023 Mar 29.
Autor:
Wang M; The University of Texas MD Anderson Cancer Center, Houston, TX., Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ., Goy A; John Theurer Cancer Center, Hackensack University, Hackensack, NJ., Locke FL; Moffitt Cancer Center, Tampa, FL., Jacobson CA; Dana-Farber Cancer Institute, Boston, MA., Hill BT; Cleveland Clinic Foundation, Cleveland, OH., Timmerman JM; David Geffen School of Medicine at UCLA, Los Angeles, CA., Holmes H; Texas Oncology, Dallas, TX., Jaglowski S; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Flinn IW; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., McSweeney PA; Colorado Blood Cancer Institute, Denver, CO., Miklos DB; Stanford University School of Medicine, Stanford, CA., Pagel JM; Swedish Cancer Institute, Seattle, WA., Kersten MJ; Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands, on behalf of HOVON/LLPC., Bouabdallah K; CHU Bordeaux, Service d'Hématologie et thérapie Cellulaire, Bordeaux, France., Khanal R; Fox Chase Cancer Center, Philadelphia, PA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Houot R; CHU Rennes, Université Rennes, INSERM & EFS, Rennes, France., Beitinjaneh A; University of Miami, Miami, FL., Peng W; Kite, a Gilead Company, Santa Monica, CA., Fang X; Kite, a Gilead Company, Santa Monica, CA., Shen RR; Kite, a Gilead Company, Santa Monica, CA., Siddiqi R; Kite, a Gilead Company, Santa Monica, CA., Kloos I; Kite, a Gilead Company, Santa Monica, CA., Reagan PM; University of Rochester Medical Center, Rochester, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 20; Vol. 41 (3), pp. 555-567. Date of Electronic Publication: 2022 Jun 04.